TAK-652 Inhibits CCR5-Mediated Human Immunodeficiency Virus Type 1 Infection In Vitro and Has Favorable Pharmacokinetics in Humans

The first small-molecule CCR5 antagonist, TAK-779, could not be developed as an anti-human immunodeficiency virus type (anti-HIV-1) agent because of its poor oral bioavailability. TAK-652 is an orally bioavailable TAK-779 derivative with potent anti-HIV-1 activity. TAK-652 inhibited the binding of R...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Baba, Masanori, Takashima, Katsunori, Miyake, Hiroshi, Kanzaki, Naoyuki, Teshima, Koichiro, Wang, Xin, Shiraishi, Mitsuru, Iizawa, Yuji
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2005
Témata:
Antiviral Agents
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1280155/
https://ncbi.nlm.nih.gov/pubmed/16251299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.11.4584-4591.2005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky